Multidisciplinary Design to Optimize Schizophrenia Treatment Based on Multi-omics Data and Systems Biology Analysis

Clinical trial NCT06060886 · UNKNOWN

Trial details

NCT number: NCT06060886
Sponsor: Consorcio Centro de Investigación Biomédica en Red (CIBER)
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Schizophrenia Treatment-resistant Schizophrenia Side Effect Lipid Metabolism Disorders Diabetes NAFLD Psychosis

Start date: 2023-11-01
Primary completion: 2025-06-01
Enrollment: 244

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.